Management of oral mucositis in patients with cancer

European Journal of Oncology Nursing

Volumn 9, Issue SUPPL. 1, 2005, Pages

  Stone, Rebecca ^a   Fliedner, Monica C ^b   Smiet, Antoine C M ^c  

^a NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

^b UNIVERSITY OF BERN   (Switzerland)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Management; Nursing; Oral mucositis; Prevention; Treatment

Indexed keywords

KERATINOCYTE GROWTH FACTOR;

ARTICLE; HUMAN; NEOPLASM; NURSING; NURSING ASSESSMENT; PATIENT EDUCATION; PRACTICE GUIDELINE; STOMATITIS;

FIBROBLAST GROWTH FACTOR 7; HUMANS; NEOPLASMS; NURSING ASSESSMENT; PATIENT EDUCATION; PRACTICE GUIDELINES; STOMATITIS;

EID: 27144440829     PISSN: 14623889     EISSN: 15322122     Source Type: Journal    
DOI: 10.1016/j.ejon.2005.08.004     Document Type: Article

References (33)

1. E.B. Avritscher C.D. Cooksley L.S. Elting Scope and epidemiology of cancer therapy-induced oral and gastrointestinal mucositis Seminars in Oncology Nursing 20 2004 3-10
2. L.A. Bellm J.B. Epstein A.M. Rose-Ped P. Martin H.J. Fuchs Patient reports of complications of bone marrow transplantation Supportive Care in Cancer 8 2000 33-39
3. G. Bonadonna A. Moliterni M. Zambetti M.G. Daidone S. Pilotti L. Gianni P. Valagussa 30 years' follow up of randomised studies of adjuvant CMF in operable breast cancer: Cohort study British Medical Journal 330 2005 217
4. S. Borbasi K. Comeron B. Quested I. Olver B. To D. Evans More than a sore mouth: Patients' experience of oral mucositis Oncology Nursing Forum 29 2002 1051-1057
5. C.G. Brown J. Wingard Clinical consequences of oral mucositis Seminars in Oncology Nursing 20 2004 16-21
6. B.A. Coda B. O'Sullivan G. Donaldson S. Bohl C.R. Chapman D.D. Shen Comparative efficacy of patient-controlled administration of morphine, hydromorphone, or sufentanil for the treatment of oral mucositis pain following bone marrow transplantation Pain 72 1997 333-346
7. J.D. Cox T.F. Pajak V.A. Marcial L. Coia M. Mohiuddin K.K. Fu H.M. Selim R.W. Byhardt P. Rubin H.G. Ortiz L. Martin Interruptions adversely affect local control and survival with hyperfractionated radiation therapy of carcinomas of the respiratory/digestive tracts. New evidence for accelerated proliferation from RTOG Protocol 83-13 Cancer 69 1992 2744-2748
8. B.T. Daniel K.L. Damato J. Johnson Educational issues in oral care Seminars in Oncology Nursing 20 2004 48-52
9. M.J. Dodd N.C. Facione S.L. Dibble L. MacPhail Comparison of methods to determine the prevalence and nature of oral mucositis Cancer Practice 4 1996 312-318
10. S. Dyck K. Brett B. Davies Development of a staging system for chemotherapy-induced stomatitis. Western Consortium for Cancer Nursing Research Cancer Nursing 14 1991 6-12
11. J. Eilers A. Berger M. Petersen Development, testing and application of the oral assessment guide Oncology Nursing Forum 15 1988 325-330
12. J. Eilers J.B. Epstein Assessment and measurement of oral mucositis Seminars in Oncology Nursing 20 2004 22-29
13. L.S. Elting C. Cooksley M. Chambers S.B. Cantor E. Manzullo E.B. Rubenstein The burdens of cancer therapy - Clinical and economic outcomes of chemotherapy-induced mucositis Cancer 98 2003 1531-1539
14. J.B. Epstein M. Robertson S. Emerton N. Phillips P. Stevenson-Moore Quality of life and oral function in patients treated with radiation therapy for head and neck cancer Head and Neck 23 2001 389-398
15. J.B. Epstein P.J. Hancock S. Nantel Oral candidiasis in hematopoietic cell transplantation patients: An outcome-based analysis Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics 96 2003 154-163
16. J.F. Fowler M.J. Lindstrom Loss of local control with prolongation in radiotherapy International Journal of Radiation Oncology, Biology, Physics 23 1992 457-467
17. Kepivance™ (palifermin). [package insert]. Thousand Oaks, CA: Amgen Inc; 2004.
18. D.L. Kwong J.S. Sham D.T. Chua D.T. Choy G.K. Au P.M. Wu The effect of interruptions and prolonged treatment time in radiotherapy for nasopharyngeal carcinoma International Journal of Radiation Oncology, Biology, Physics 39 1997 703-710
19. B. Maciejewski H.R. Withers J.M. Taylor A. Hliniak Dose fractionation and regeneration in radiotherapy for cancer of the oral cavity and oropharynx: Tumor dose-response and repopulation International Journal of Radiation Oncology, Biology, Physics 16 1989 831-843
20. National Cancer Institute Common Toxicity Criteria. Version 2.0, June 1, 1999. Available at: http://ctep.info.nih.gov. Accessed July 22, 2005. Geneva, Switzerland.
21. Oster, G., Vera-Llonch, M., Ford, C., Lu, J., Khazanov, I., Sonis, S., 2005. Oral mucositis (OM) and outcomes of allogeneic hematopoietic stem cell transplantation (HSCT) [abstract]. In: 17th MASCC International Symposium, June 30-July 2, 2005, Geneva, Switzerland. Abstract 15-107.
22. D.E. Peterson S.L. Beck D.M.K. Keefe Novel therapies Seminars in Oncology Nursing 20 2004 53-58
23. A.M. Rose-Ped L.A. Bellm J.B. Epstein A. Trotti C. Gwede H.J. Fuchs Complications of radiation therapy for head and neck cancers. The patient's perspective Cancer Nursing 25 2002 461-467
24. E.B. Rubenstein D.E. Peterson M. Schubert D. Keefe D. McGuire J. Epstein L.S. Elting P.C. Fox C. Cooksley S.T. Sonis Clinical practice guidelines for the prevention and treatment of cancer therapy-induced oral and gastrointestinal mucositis Cancer 100 9 Suppl. 2004 2026-2046
25. A. Shih C. Miaskowski M.J. Dodd N.A. Stotts L. MacPhail A research review of the current treatments for radiation-induced oral mucositis in patients with head and neck cancer Oncology Nursing Forum 29 2002 1063-1078
26. S.T. Sonis J.P. Eilers J.B. Epstein F.G. LeVeque W.H. Liggett Jr. M.T. Mulagha D.E. Peterson A.H. Rose M.M. Schubert F.K. Spijkervet J.P. Wittes Validation of a new scoring system for the assessment of clinical trial research of oral mucositis induced by radiation or chemotherapy Cancer 85 1999 2103-2113
27. S.T. Sonis Oral mucositis and the clinical and economic outcomes of hematopoietic stem-cell transplantation Journal of Clinical Oncology 19 2001 2201-2205
28. S.T. Sonis The pathobiology of mucositis Nature Reviews 4 2004 277-284
29. R. Spielberger P. Stiff W. Bensinger T. Gentile D. Weisdorf T. Kewalramani T. Shea S. Yanovich K. Hansen S. Noga J. McCarty C.F. LeMaistre E.C. Sung B.R. Blazar D. Elhardt M.G. Chen C. Emmanouilides Palifermin for oral mucositis after intensive therapy for hematologic cancers New England Journal of Medicine 351 2004 2590-2598
30. P. Stiff C. Emmanouilides S. Durrant D. Blaise U. Gayko R. Spielberger No difference in survival between palifermin-treated and placebo-treated patients (pts) with hematologic malignancies (HM) in the autologous hematopoietic stem cell transplant (HSCT) setting [abstract] Supportive Care in Cancer 13 2005 448 Abstract 15-109
31. Stone, R., Clare, S., Potting, C., Davies, M., Mank, A., Quinn, B., Uhlenhopp, M., on behalf of the EBMT Nurses Group, 2005. Current practices for prevention and treatment of oral mucositis in adult patients with haematological malignancies undergoing bone marrow/ peripheral blood progenitor cell transplantation: A survey of European transplant centres. 31st Annual Meeting of the European Group for Blood and Marrow Transplantation, Prague, Czech Republic, March 20-23, 2005. Presentation N920.
32. World Health Organization Handbook for Reporting Results of Cancer Treatment 1979 World Health Organization Geneva, Switzerland pp. 15-22
33. H.V. Worthington J.E. Clarkson O.B. Eden Interventions for treating oral mucositis for patients with cancer receiving treatment Cochrane Database of Systematic Reviews 3 2005 CD001973